An International Classification of Hyperlipidemias and Hyperlipoproteinemias
Authors: DONALD S. FREDRICKSON
Journal: Annals of Internal Medicine (1971)

Editorial Notes1 September 1971An International Classification of Hyperlipidemias and HyperlipoproteinemiasDONALD S. FREDRICKSON, M.D.DONALD S. FREDRICKSON, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-75-3-471 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptA memorandum recommending a provisional and internationally acceptable classification of hyperlipidemias and hyperlipoproteinemias has appeared in a recent issue of the Bulletin of the World Health Organization (1). The recommendations are the product of an informal meeting convened in Geneva in June 1970, by Dr. Z. Fejfar, Chief of the WHO Section on Cardiovascular Diseases. The other participants included Drs. J. L. Beaumont from Paris, L. A. Carlson from Uppsala, G. R. Cooper from Atlanta, T. Strasser from Geneva, and myself.Although the weather in Geneva tends to be oppressive in early summer, the climate of the meeting was most...References1. BEAUMONTCARLSONCOOPER JLG: Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull WHO 43:891-915, 1970 MedlineGoogle Scholar2. FREDRICKSONLEVYLEES DRR: Fat transport in lipoproteins: an integrated approach to mechanisms and disorders. N Engl J Med 276:34-44, 94-103, 148-156, 215-226, 273-281, 1967 CrossrefMedlineGoogle Scholar3. FREDRICKSONLEVY DR: Familial hyperlipoproteinemia, in The Metabolic Basis of Inherited Disease, 3rd ed., edited by STANBURY JB, WYNGAARDEN JB, FREDRICKSON DS. New York, The McGraw-Hill Book Co., 1972, pp. 545-614 Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: National Heart and Lung Institute National Institutes of Health Bethesda, Md. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byHypertriglyceridemia-Induced Acute Pancreatitis, Euglycemic Diabetic Ketoacidosis and COVID-19 Infection in a Patient With Type 2 Diabetes Taking a Sodium-Glucose Cotransporter 2 InhibitorEfficacy of Majoon-e-Seer Alvi Khan in dyslipidemia: a single blind randomized standard controlled clinical trialUnderstanding the Connection Between Common Stroke Comorbidities, Their Associated Inflammation, and the Course of the Cerebral Ischemia/Reperfusion CascadeEfficacy of Majoon-e-Seer Alvi Khan in dyslipidemia: a single blind randomized standard controlled clinical trialIndicators of lipid metabolism disorders in the blood serum of adolescents with metabolic syndromeTrigliserit yüksekliği olan bir hastada akut pankreatit gelişimi: Olgu sunumuHypertriglyceridemia and acute pancreatitisUsing syndemic theory to understand food insecurity and diet-related chronic diseasesInnovatively Established Analysis Method for Lipoprotein Profiles Based on High-Performance Anion-Exchange Liquid ChromatographyDiabetic dyslipidemia: evaluation and mechanismAn Update on Hypertriglyceridemia-Induced Acute PancreatitisNew treatment options for lipid-lowering therapy in subjects with type 2 diabetesAcute PancreatitisFamilial dysbetalipoproteinemiaHypertriglyceridemia: the importance of identifying patients at riskRare genetic variants with large effect on triglycerides in subjects with a clinical diagnosis of familial vs nonfamilial hypertriglyceridemiaEmTriglyceride-Induced Pancreatitis: Diagnostic and Therapeutic ApproachChylomicrons: Advances in biology, pathology, laboratory testing, and therapeuticsUpdate on the molecular biology of dyslipidemiasAbdominal pain in hypertriglyceridemiaCorneal arcus as the first presentation of hypercholesterolemia in childrenMolecular analysis of chylomicronemia in a clinical laboratory setting: Diagnosis of 13 cases of lipoprotein lipase deficiencyAcute PancreatitisDiabetic Ketoacidosis-induced Hypertriglyceridemic Acute Pancreatitis Treated with Plasmapheresis—Recipe for Biochemical Disaster ManagementPankreatitis - ein ÜberblickLipid-Associated Rheumatologic SyndromesHipertrigliseridemiye bağlı akut pankreatit tedavisinde plazmaferezThe Sweet Spot: Continued Search for the Glycemic Threshold for Macrovascular Disease—A Retrospective Single Center ExperiencePersistent Hemolysis in a Patient with PancreatitisPrésentation inhabituelle d’une pancréatite aiguë hypertriglycéridémique chez un enfantInitial Description of Cerebral Oximetry Measurement in Heart Failure PatientsL’édifiante histoire du cholestérol : de la pierre de fiel au récepteur aux LDLDyslipidemiaTiming clinical events in the treatment of pancreatitis and hypertriglyceridemia with therapeutic plasmapheresisGenetic bases of hypertriglyceridemic phenotypesA classification of lipoprotein disorders: implications for clinical managementHypertriglyceridaemia, LPL deficiency and pancreatitis -pathogenesis and therapeutic optionsNiacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular riskSevere Hypertriglyceridemia: An indication for apheresis?Severe hypertriglyceridemia and pancreatitis: presentation and managementHypertriglyceridemic Pancreatitis: Presentation and ManagementHyperlipidemia in the ElderlyDiabetic Dyslipidemia and AtherosclerosisThe metabolic syndrome: definition, pathogenesis and therapyTime to move to an integral approach for diagnosis and treatment of the metabolic syndromeHepatic Steatosis in Dunnigan-Type Familial Partial LipodystrophyDyslipemia in Familial Partial Lipodystrophy Caused by an R482W Mutation in the LMNA GeneEpidemiologie und Prävention der koronaren HerzkrankheitEpidemiologie der coronaren Herzerkrankung — Korrektur von RisikofaktorenHyperlipidemiaCoronarerkrankungenClofibrate in Type II HyperlipoproteinemiaHypercholesterolemia and hypertriglyceridemia in childrenLIPOPROTEIN LIPASE ACTIVITY OF HUMAN ADIPOSE TISSUE IN DIFFERENT TYPES OF HYPERLIPIDEMIAThe indirect confirmation of hyperlipoproteinemia phenotypes II, III and IVFamilial Hypercholesterolemia in a Large Kindred Evidence for a Monogenic MechanismHELMUT G. SCHROTT, M.D., JOSEPH L. GOLDSTEIN, M.D., WILLIAM R. HAZZARD, M.D., MICHAEL M. MCGOODWIN, M.D., ARNO G. MOTULSKY, M.D., F.A.C.P. 1 September 1971Volume 75, Issue 3Page: 471-472KeywordsCardiovascular diseasesGlobal healthHyperlipidemia Issue Published: 1 September 1971 PDF downloadLoading ...